158 related articles for article (PubMed ID: 37148862)
21. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
22. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.
Sheng L; Jena PK; Hu Y; Liu HX; Nagar N; Kalanetra KM; French SW; French SW; Mills DA; Wan YY
J Pathol; 2017 Dec; 243(4):431-441. PubMed ID: 28892150
[TBL] [Abstract][Full Text] [Related]
23. Western Diet Aggravated Carbon Tetrachloride-Induced Chronic Liver Injury by Disturbing Gut Microbiota and Bile Acid Metabolism.
Yang L; Li Y; Wang S; Bian X; Jiang X; Wu J; Wang K; Wang Q; Xia J; Jiang S; Zhuge A; Yuan Y; Li S; Li L
Mol Nutr Food Res; 2021 Apr; 65(7):e2000811. PubMed ID: 33458949
[TBL] [Abstract][Full Text] [Related]
24. Jiang-Tang-San-Huang pill alleviates type 2 diabetes mellitus through modulating the gut microbiota and bile acids metabolism.
Tawulie D; Jin L; Shang X; Li Y; Sun L; Xie H; Zhao J; Liao J; Zhu Z; Cui H; Wen W
Phytomedicine; 2023 May; 113():154733. PubMed ID: 36870307
[TBL] [Abstract][Full Text] [Related]
25. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis.
Ling CJ; Xu JY; Li YH; Tong X; Yang HH; Yang J; Yuan LX; Qin LQ
Food Funct; 2019 Nov; 10(11):7299-7307. PubMed ID: 31626262
[TBL] [Abstract][Full Text] [Related]
26. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
27. DEHP induce cholesterol imbalance via disturbing bile acid metabolism by altering the composition of gut microbiota in rats.
Yu Z; Shi Z; Zheng Z; Han J; Yang W; Lu R; Lin W; Zheng Y; Nie D; Chen G
Chemosphere; 2021 Jan; 263():127959. PubMed ID: 32814133
[TBL] [Abstract][Full Text] [Related]
28. Gut Microbiota Modulation Attenuated the Hypolipidemic Effect of Simvastatin in High-Fat/Cholesterol-Diet Fed Mice.
He X; Zheng N; He J; Liu C; Feng J; Jia W; Li H
J Proteome Res; 2017 May; 16(5):1900-1910. PubMed ID: 28378586
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.
Li T; Matozel M; Boehme S; Kong B; Nilsson LM; Guo G; Ellis E; Chiang JY
Hepatology; 2011 Mar; 53(3):996-1006. PubMed ID: 21319191
[TBL] [Abstract][Full Text] [Related]
30. Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism.
Huang F; Zheng X; Ma X; Jiang R; Zhou W; Zhou S; Zhang Y; Lei S; Wang S; Kuang J; Han X; Wei M; You Y; Li M; Li Y; Liang D; Liu J; Chen T; Yan C; Wei R; Rajani C; Shen C; Xie G; Bian Z; Li H; Zhao A; Jia W
Nat Commun; 2019 Oct; 10(1):4971. PubMed ID: 31672964
[TBL] [Abstract][Full Text] [Related]
31. Sterol 12α-Hydroxylase Aggravates Dyslipidemia by Activating the Ceramide/mTORC1/SREBP-1C Pathway via FGF21 and FGF15.
Pathak P; Chiang JYL
Gene Expr; 2019 Nov; 19(3):161-173. PubMed ID: 30890204
[TBL] [Abstract][Full Text] [Related]
32. Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway.
Luo M; Yan J; Wu L; Wu J; Chen Z; Jiang J; Chen Z; He B
J Immunol Res; 2021; 2021():2264737. PubMed ID: 34458376
[TBL] [Abstract][Full Text] [Related]
33. Polysaccharides from
Yang C; Huang S; Lin Z; Chen H; Xu C; Lin Y; Sun H; Huang F; Lin D; Guo F
Food Funct; 2022 Nov; 13(23):12194-12207. PubMed ID: 36331041
[TBL] [Abstract][Full Text] [Related]
34. n-3 Fatty Acids Abrogate Dyslipidemia-Induced Changes in Bile Acid Uptake, Synthesis, and Transport in Young and Aged Dyslipidemic Rats.
Acharya P; Talahalli RR
Lipids; 2019 Jan; 54(1):39-51. PubMed ID: 30740707
[TBL] [Abstract][Full Text] [Related]
35. The hypocholesterolemic activity of Momordica charantia fruit is mediated by the altered cholesterol- and bile acid-regulating gene expression in rat liver.
Matsui S; Yamane T; Takita T; Oishi Y; Kobayashi-Hattori K
Nutr Res; 2013 Jul; 33(7):580-5. PubMed ID: 23827133
[TBL] [Abstract][Full Text] [Related]
36. [Heat-inactivated Streptococcus thermophilus MN002 alleviate lipid metabolism of high fat diet-fed induced obese mice through modulating gut microbiota structure and bile acids].
Zhao J; Luo Y; Li Y; Cheng R; Shen X; Chen J; Kang X; Li Z; He F
Wei Sheng Yan Jiu; 2023 Mar; 52(2):259-264. PubMed ID: 37062689
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury.
Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K
Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034
[TBL] [Abstract][Full Text] [Related]
38. Berberine alleviates cholesterol and bile acid metabolism disorders induced by high cholesterol diet in mice.
Wang Q; Shen W; Shao W; Hu H
Biochem Biophys Res Commun; 2024 Jul; 719():150088. PubMed ID: 38740003
[TBL] [Abstract][Full Text] [Related]
39. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
[TBL] [Abstract][Full Text] [Related]
40. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
